{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:10:54Z","timestamp":1789539054655,"version":"build-2803163510"},"reference-count":51,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2022.20925","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T15:32:21Z","timestamp":1657294341000},"page":"e2220925","source":"Crossref","is-referenced-by-count":46,"title":["Evaluation of Rituximab for Induction and Maintenance Therapy in Patients 75 Years and Older With Antineutrophil Cytoplasmic Antibody\u2013Associated Vasculitis"],"prefix":"10.1001","volume":"5","author":[{"given":"Sara","family":"Thietart","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, H\u00f4pital Cochin, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris, France"},{"name":"Department of Geriatrics, Sorbonne Universit\u00e9, Assistance Publique\u2013H\u00f4pitaux de Paris, Groupe Hospitalier Piti\u00e9-Salp\u00eatri\u00e8re-Charles Foix, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Karras","sequence":"additional","affiliation":[{"name":"Department of Nephrology, H\u00f4pital Europ\u00e9en Georges Pompidou, Assistance Publique\u2013H\u00f4pitaux de Paris, Universit\u00e9 de Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Augusto","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Dialysis, and Transplantation, Centre Hospitalier Universitaire, Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Philipponnet","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Centre Hospitalier Universitaire, Clermont-Ferrand, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Louis","family":"Carron","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Dialysis, and Transplantation, Centre Hospitalier Universitaire Grenoble-Alpes, Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Delbrel","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Centre Hospitalier de Pau, Pau, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafik","family":"Mesbah","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Centre Hospitalier, Boulogne-sur-Mer, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Blaison","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Louis Pasteur Colmar Hospital, Colmar, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Duffau","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Centre Hospitalier Universitaire Bordeaux, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalil","family":"El Karoui","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Renal Transplantation, H\u00f4pital Henri-Mondor, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perrine","family":"Smets","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Centre Hospitalier Universitaire Gabriel Montpied, Clermont-Ferrand, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"London","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, H\u00f4pital Cochin, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris, France"},{"name":"Department of Internal Medicine, Groupe Hospitalier Diaconesses Croix Saint Simon, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Mouthon","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, H\u00f4pital Cochin, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris, France"},{"name":"Assistance Publique\u2013H\u00f4pitaux de Paris Centre, Universit\u00e9 Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efc","family":"Guillevin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, H\u00f4pital Cochin, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris, France"},{"name":"Assistance Publique\u2013H\u00f4pitaux de Paris Centre, Universit\u00e9 Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Terrier","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, H\u00f4pital Cochin, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris, France"},{"name":"Assistance Publique\u2013H\u00f4pitaux de Paris Centre, Universit\u00e9 Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Pu\u00e9chal","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, H\u00f4pital Cochin, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris, France"},{"name":"Assistance Publique\u2013H\u00f4pitaux de Paris Centre, Universit\u00e9 Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"French Vasculitis Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Alla","sequence":"additional","affiliation":[{"name":"for the French Vasculitis Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Audard","sequence":"additional","affiliation":[{"name":"for the French Vasculitis Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Auma\u00eetre","sequence":"additional","affiliation":[{"name":"for the French Vasculitis Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Bally","sequence":"additional","affiliation":[{"name":"for the French Vasculitis Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Bonnotte","sequence":"additional","affiliation":[{"name":"for the French Vasculitis Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Charles","sequence":"additional","affiliation":[{"name":"for the French Vasculitis Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Cohen","sequence":"additional","affiliation":[{"name":"for the French Vasculitis Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Corbel","sequence":"additional","affiliation":[{"name":"for the French Vasculitis Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"Cousin","sequence":"additional","affiliation":[{"name":"for the French Vasculitis Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoann","family":"Cabrol","sequence":"additional","affiliation":[{"name":"for the French Vasculitis Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Durupt","sequence":"additional","affiliation":[{"name":"for the French Vasculitis Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Faucher","sequence":"additional","affiliation":[{"name":"for the French Vasculitis Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9gol\u00e8ne","family":"Gendreau","sequence":"additional","affiliation":[{"name":"for the French Vasculitis Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Girszyn","sequence":"additional","affiliation":[{"name":"for the French Vasculitis Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Godmer","sequence":"additional","affiliation":[{"name":"for the French Vasculitis Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Hamidou","sequence":"additional","affiliation":[{"name":"for the French Vasculitis Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00e9mie","family":"Jourde-Chiche","sequence":"additional","affiliation":[{"name":"for the French Vasculitis Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeline","family":"Lacraz","sequence":"additional","affiliation":[{"name":"for the French Vasculitis Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Landron","sequence":"additional","affiliation":[{"name":"for the French Vasculitis Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Le Jeunne","sequence":"additional","affiliation":[{"name":"for the French Vasculitis Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Lifermann","sequence":"additional","affiliation":[{"name":"for the French Vasculitis Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Liozon","sequence":"additional","affiliation":[{"name":"for the French Vasculitis Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Marchand-Adam","sequence":"additional","affiliation":[{"name":"for the French Vasculitis Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Maurier","sequence":"additional","affiliation":[{"name":"for the French Vasculitis Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ars\u00e8ne","family":"M\u00e9kinian","sequence":"additional","affiliation":[{"name":"for the French Vasculitis Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Pagnoux","sequence":"additional","affiliation":[{"name":"for the French Vasculitis Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Qu\u00e9m\u00e9neur","sequence":"additional","affiliation":[{"name":"for the French Vasculitis Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviane","family":"Queyrel","sequence":"additional","affiliation":[{"name":"for the French Vasculitis Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanta Nirina","family":"Rakotoarivelo","sequence":"additional","affiliation":[{"name":"for the French Vasculitis Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"R\u00e9gent","sequence":"additional","affiliation":[{"name":"for the French Vasculitis Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quitterie","family":"Reynaud","sequence":"additional","affiliation":[{"name":"for the French Vasculitis Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Rieu","sequence":"additional","affiliation":[{"name":"for the French Vasculitis Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Sacre","sequence":"additional","affiliation":[{"name":"for the French Vasculitis Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Soto","sequence":"additional","affiliation":[{"name":"for the French Vasculitis Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri","family":"Titeca-Beauport","sequence":"additional","affiliation":[{"name":"for the French Vasculitis Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Vinzio","sequence":"additional","affiliation":[{"name":"for the French Vasculitis Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,7,8]]},"reference":[{"issue":"1","key":"zoi220598r1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 Revised International Chapel Hill Consensus Conference nomenclature of vasculitides.","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"12","key":"zoi220598r2","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1093\/rheumatology\/kep304","article-title":"Incidence and survival rates in Wegener\u2019s granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa.","volume":"48","author":"Mohammad","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"zoi220598r3","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1093\/rheumatology\/kew232","article-title":"Incidence of ANCA-associated vasculitis in a UK mixed ethnicity population.","volume":"55","author":"Pearce","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"zoi220598r4","doi-asserted-by":"publisher","first-page":"iii42","DOI":"10.1093\/rheumatology\/keaa089","article-title":"An update on the epidemiology of ANCA-associated vasculitis.","volume":"59","author":"Mohammad","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"zoi220598r5","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/rheumatology\/keh522","article-title":"ANCA-associated renal vasculitis at the end of the twentieth century\u2014a disease of older patients.","volume":"44","author":"Harper","year":"2005","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"zoi220598r6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/MD.0b013e31817c744b","article-title":"Antineutrophil cytoplasmic autoantibody\u2013associated vasculitis in older patients.","volume":"87","author":"Chen","year":"2008","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"zoi220598r7","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/joim.v291.3","article-title":"Patients of 75 years and over with ANCA-associated vasculitis have a lower relapse risk than younger patients: a multicentre cohort study.","volume":"291","author":"Thietart","year":"2022","journal-title":"J Intern Med"},{"issue":"2","key":"zoi220598r8","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/rheumatology\/keaa215","article-title":"Association between age at disease onset of anti-neutrophil cytoplasmic antibody\u2013associated vasculitis and clinical presentation and short-term outcomes.","volume":"60","author":"Monti","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"zoi220598r9","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1093\/rheumatology\/kez388","article-title":"Long-term outcomes in elderly patients with ANCA-associated vasculitis.","volume":"59","author":"McGovern","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"zoi220598r10","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/s12882-018-1102-3","article-title":"Early predictors of one-year mortality in patients over 65 presenting with ANCA-associated renal vasculitis: a retrospective, multicentre study.","volume":"19","author":"Titeca-Beauport","year":"2018","journal-title":"BMC Nephrol"},{"issue":"3","key":"zoi220598r11","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis.","volume":"363","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"issue":"3","key":"zoi220598r12","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"issue":"19","key":"zoi220598r13","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1056\/NEJMoa1404231","article-title":"Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis.","volume":"371","author":"Guillevin","year":"2014","journal-title":"N Engl J Med"},{"issue":"8","key":"zoi220598r14","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1136\/annrheumdis-2017-212768","article-title":"Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitides.","volume":"77","author":"Terrier","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"zoi220598r15","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/rheumatology\/key117","article-title":"Rituximab for induction and maintenance therapy of granulomatosis with polyangiitis: a single-centre cohort study on 114 patients.","volume":"58","author":"Pu\u00e9chal","year":"2019","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"zoi220598r16","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1136\/annrheumdis-2017-211123","article-title":"Randomised controlled trial of prolonged treatment in the remission phase of ANCA-associated vasculitis.","volume":"76","author":"Karras","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"zoi220598r17","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1136\/annrheumdis-2017-212878","article-title":"Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2).","volume":"77","author":"Charles","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"zoi220598r18","doi-asserted-by":"publisher","first-page":"179","DOI":"10.7326\/M19-3827","article-title":"Long-term rituximab use to maintain remission of antineutrophil cytoplasmic antibody\u2013associated vasculitis: a randomized trial.","volume":"173","author":"Charles","year":"2020","journal-title":"Ann Intern Med"},{"issue":"21","key":"zoi220598r19","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1001\/jama.2010.1658","article-title":"Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody\u2013associated vasculitis: a randomized controlled trial.","volume":"304","author":"Hiemstra","year":"2010","journal-title":"JAMA"},{"issue":"4","key":"zoi220598r20","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1056\/NEJMoa041884","article-title":"Etanercept plus standard therapy for Wegener\u2019s granulomatosis.","volume":"352","author":"Wegener\u2019s Granulomatosis Etanercept Trial (WGET) Research Group","year":"2005","journal-title":"N Engl J Med"},{"issue":"7","key":"zoi220598r21","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1056\/NEJMoa1803537","article-title":"Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis.","volume":"382","author":"Walsh","year":"2020","journal-title":"N Engl J Med"},{"issue":"7","key":"zoi220598r22","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa2023386","article-title":"Avacopan for the treatment of ANCA-associated vasculitis.","volume":"384","author":"Jayne","year":"2021","journal-title":"N Engl J Med"},{"issue":"4","key":"zoi220598r23","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/art.v67.4","article-title":"Treatment of systemic necrotizing vasculitides in patients aged sixty-five years or older: results of a multicenter, open-label, randomized controlled trial of corticosteroid and cyclophosphamide-based induction therapy.","volume":"67","author":"Pagnoux","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"27","key":"zoi220598r24","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.1056\/NEJMsb042458","article-title":"Potential pitfalls of disease-specific guidelines for patients with multiple conditions.","volume":"351","author":"Tinetti","year":"2004","journal-title":"N Engl J Med"},{"key":"zoi220598r25","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.281053"},{"issue":"8","key":"zoi220598r26","doi-asserted-by":"publisher","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"147","author":"von Elm","year":"2007","journal-title":"Ann Intern Med"},{"issue":"2","key":"zoi220598r27","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1136\/ard.2006.054593","article-title":"Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies.","volume":"66","author":"Watts","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"zoi220598r28","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1136\/ard.2008.101279","article-title":"Modification and validation of the Birmingham Vasculitis Activity Score (version 3).","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"zoi220598r29","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1093\/rheumatology\/keq400","article-title":"A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis.","volume":"50","author":"Suppiah","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"zoi220598r30","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1136\/ard.2006.062711","article-title":"EULAR recommendations for conducting clinical studies and\/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody\u2013associated vasculitis.","volume":"66","author":"Hellmich","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"zoi220598r31","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/00005792-199601000-00003","article-title":"Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. a prospective study in 342 patients.","volume":"75","author":"Guillevin","year":"1996","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"zoi220598r32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/MD.0b013e318205a4c6","article-title":"The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort.","volume":"90","author":"Guillevin","year":"2011","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"zoi220598r33","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/00005650-197605001-00018","article-title":"12. Index of ADL.","volume":"14","author":"Katz","year":"1976","journal-title":"Med Care"},{"issue":"21","key":"zoi220598r34","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1001\/jama.2021.6615","article-title":"Effect of reduced-dose vs high-dose glucocorticoids added to rituximab on remission induction in ANCA-associated vasculitis: a randomized clinical trial.","volume":"325","author":"Furuta","year":"2021","journal-title":"JAMA"},{"issue":"2","key":"zoi220598r35","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/rssb.1972.34.issue-2","article-title":"Regression models and life-tables.","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc B"},{"issue":"446","key":"zoi220598r36","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk.","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"2","key":"zoi220598r37","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S2213-2600(18)30345-X","article-title":"Acute respiratory failure in immunocompromised adults.","volume":"7","author":"Azoulay","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"9","key":"zoi220598r38","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1002\/acr.v66.9","article-title":"Efficacy and safety of rituximab in elderly patients with rheumatoid arthritis enrolled in a French Society of Rheumatology registry.","volume":"66","author":"Payet","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"zoi220598r39","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.semarthrit.2015.02.005","article-title":"Rituximab for remission induction in elderly patients with ANCA-associated vasculitis.","volume":"45","author":"Timlin","year":"2015","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"zoi220598r40","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1002\/acr.v73.9","article-title":"Long-term safety of rituximab in granulomatosis with polyangiitis and in microscopic polyangiitis.","volume":"73","author":"Merkel","year":"2021","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"9","key":"zoi220598r41","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1136\/annrheumdis-2019-216863","article-title":"Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis.","volume":"79","author":"Smith","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"zoi220598r42","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1136\/ard.2009.109389","article-title":"Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis.","volume":"69","author":"Little","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"zoi220598r43","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1002\/art.34584","article-title":"Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener\u2019s): ten-year experience at a single center.","volume":"64","author":"Cartin-Ceba","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"1","key":"zoi220598r44","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12882-019-1226-0","article-title":"Intravenous pulse methylprednisolone for induction of remission in severe ANCA associated vasculitis: a multi-center retrospective cohort study.","volume":"20","author":"Chanouzas","year":"2019","journal-title":"BMC Nephrol"},{"issue":"1","key":"zoi220598r45","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1159\/000509893","article-title":"Severe infections following rituximab treatment in antineutrophil cytoplasmic antibody\u2013associated vasculitis.","volume":"7","author":"Li","year":"2021","journal-title":"Kidney Dis (Basel)"},{"issue":"3","key":"zoi220598r46","doi-asserted-by":"publisher","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype.","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"9","key":"zoi220598r47","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1093\/rheumatology\/kez680","article-title":"Handgrip strength is a comorbidity marker in systemic necrotizing vasculitides and predicts the risk of fracture and serious adverse events.","volume":"59","author":"Henriquez","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"zoi220598r48","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/geront\/9.3_Part_1.179","article-title":"Assessment of older people: self-maintaining and instrumental activities of daily living.","volume":"9","author":"Lawton","year":"1969","journal-title":"Gerontologist"},{"issue":"4","key":"zoi220598r49","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/jgs.2005.53.issue-4","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"zoi220598r50","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1503\/cmaj.050051","article-title":"A global clinical measure of fitness and frailty in elderly people.","volume":"173","author":"Rockwood","year":"2005","journal-title":"CMAJ"},{"issue":"4","key":"zoi220598r51","doi-asserted-by":"publisher","first-page":"M221","DOI":"10.1093\/gerona\/55.4.M221","article-title":"Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery.","volume":"55","author":"Guralnik","year":"2000","journal-title":"J Gerontol A Biol Sci Med Sci"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2794025\/thietart_2022_oi_220598_1656522099.42279.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T15:32:23Z","timestamp":1657294343000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2794025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,8]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.20925","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,8]]}}}